[HTML][HTML] An anti-influenza combined therapy assessed by single cell RNA-sequencing
C Medaglia, I Kolpakov, ACA Zwygart, Y Zhu… - Communications …, 2022 - nature.com
Influenza makes millions of people ill every year, placing a large burden on the healthcare
system and the economy. To develop a treatment against influenza, we combined virucidal …
system and the economy. To develop a treatment against influenza, we combined virucidal …
An anti-influenza combined therapy assessed by single cell RNA-sequencing.
C Medaglia, I Kolpakov, AC Zwygart, Y Zhu… - Communications …, 2022 - europepmc.org
Influenza makes millions of people ill every year, placing a large burden on the healthcare
system and the economy. To develop a treatment against influenza, we combined virucidal …
system and the economy. To develop a treatment against influenza, we combined virucidal …
[HTML][HTML] An anti-influenza combined therapy assessed by single cell RNA-sequencing
C Medaglia, I Kolpakov, ACA Zwygart, Y Zhu… - Communications …, 2022 - ncbi.nlm.nih.gov
Influenza makes millions of people ill every year, placing a large burden on the healthcare
system and the economy. To develop a treatment against influenza, we combined virucidal …
system and the economy. To develop a treatment against influenza, we combined virucidal …
An anti-influenza combined therapy assessed by single cell RNA-sequencing
C Medaglia, I Kolpakov, Y Zhu, S Constant… - Communications …, 2022 - infoscience.epfl.ch
Influenza makes millions of people ill every year, placing a large burden on the healthcare
system and the economy. To develop a treatment against influenza, we combined virucidal …
system and the economy. To develop a treatment against influenza, we combined virucidal …
An anti-influenza combined therapy assessed by single cell RNA-sequencing
C Medaglia, I Kolpakov, ACA Zwygart… - Communications …, 2022 - search.proquest.com
Influenza makes millions of people ill every year, placing a large burden on the healthcare
system and the economy. To develop a treatment against influenza, we combined virucidal …
system and the economy. To develop a treatment against influenza, we combined virucidal …
[PDF][PDF] An anti-infiuenza combined therapy assessed by single cell RNA-sequencing
C Medaglia, I Kolpakov, ACA Zwygart, Y Zhu… - serval.unil.ch
H1N1 IAV ex vivo. We optimized an IFN λ1/6'SLN-CD formulation to inhibit IAV in ex vivo 3D
HAE. The tissues were infected with a clinical A/Switzerland/3076/2016 H1N1 strain that has …
HAE. The tissues were infected with a clinical A/Switzerland/3076/2016 H1N1 strain that has …
[引用][C] An anti-influenza combined therapy assessed by single cell RNA-sequencing
C Medaglia, I Kolpakov, ACA Zwygart, Y Zhu… - 2022 - agris.fao.org
An anti-influenza combined therapy assessed by single cell RNA-sequencing Food and
Agriculture Organization of the United Nations Discover About FAO News Multimedia Main topics …
Agriculture Organization of the United Nations Discover About FAO News Multimedia Main topics …
An anti-influenza combined therapy assessed by single cell RNA-sequencing.
C Medaglia, I Kolpakov, ACA Zwygart… - Communications …, 2022 - search.ebscohost.com
Influenza makes millions of people ill every year, placing a large burden on the healthcare
system and the economy. To develop a treatment against influenza, we combined virucidal …
system and the economy. To develop a treatment against influenza, we combined virucidal …
An anti-influenza combined therapy assessed by single cell RNA-sequencing
C Medaglia, I Kolpakov, ACA Zwygart… - Communications …, 2022 - pubmed.ncbi.nlm.nih.gov
Influenza makes millions of people ill every year, placing a large burden on the healthcare
system and the economy. To develop a treatment against influenza, we combined virucidal …
system and the economy. To develop a treatment against influenza, we combined virucidal …
[PDF][PDF] An anti-infiuenza combined therapy assessed by single cell RNA-sequencing
C Medaglia, I Kolpakov… - …, 2022 - access.archive-ouverte.unige.ch
H1N1 IAV ex vivo. We optimized an IFN λ1/6'SLN-CD formulation to inhibit IAV in ex vivo 3D
HAE. The tissues were infected with a clinical A/Switzerland/3076/2016 H1N1 strain that has …
HAE. The tissues were infected with a clinical A/Switzerland/3076/2016 H1N1 strain that has …